Recall Z-0528-2019— Becton Dickinson & Co.
Class II · Terminated
Class II FDA medical device recall by Becton Dickinson & Co., initiated 2018-10-22, terminated 2020-04-03. FDA's recall record names no specific 510(k) clearance for this event. Product: BD BBL Trypticase Soy Agar with 5% Sheep Blood, Catalog No. 221261, (non-selective, non-differential). Reason: a portion of a single lot was not manufactured in accordance with the internal formulation resulting in inhibited growth of Gram negative organisms..
- Recalling firm
- Becton Dickinson & Co.
- Classification
- Class II
- Status
- Terminated
- Initiated
- 2018-10-22
- Terminated
- 2020-04-03
- Firm location
- Sparks, MD, United States
Product description
BD BBL Trypticase Soy Agar with 5% Sheep Blood, Catalog No. 221261, (non-selective, non-differential)
Reason for recall
a portion of a single lot was not manufactured in accordance with the internal formulation resulting in inhibited growth of Gram negative organisms.
Data sourced from openFDA. This site is unofficial and independent of the FDA.